Touyun Biotech Group Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced net loss was HKD 61.372 million compared to HKD 82.221 million a year ago. Basic loss per share from continuing operations was HKD 0.022 compared to HKD 0.0319 a year ago.